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Abstract
The in silico design of peptides and proteins as binders is useful for
diagnosis and therapeutics due to their low adverse effects and major
specificity. To select the most promising candidates, a key matter is to
understand their interactions with protein targets. In this work, we present
PARCE, an open source Protocol for Amino acid Refinement through
Computational Evolution that implements an advanced and promising
method for the design of peptides and proteins. The protocol performs a
random mutation in the binder sequence, then samples the bound
conformations using molecular dynamics simulations, and evaluates the
protein-protein interactions from multiple scoring. Finally, it accepts or
rejects the mutation by applying a consensus criterion based on binding
scores. The procedure is iterated with the aim to explore efficiently novel
sequences with potential better affinities toward their targets. We also
provide a tutorial for running and reproducing the methodology.
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Program Title: PARCE
Licensing provisions: MIT License
Programming language: Python 3
Operating system: Linux, and docker container available to run the protocol
under other operating systems.
Subprograms used: Gromacs 5.1.4, Scwrl 4, PDB2PQR, Scoring functions source
code.
Nature of problem: Computational design of peptides and proteins as binders for
diagnosis and therapeutics.
Solution method: A protocol that performs random mutations in the binder
sequence, samples the bound conformations using molecular dynamics
simulations, and evaluates the protein-protein interactions from multiple scoring
predictions in order to accept or reject the mutations.
Additional comments: This article describes version 1.0. PARCE is available at:
https://github.com/PARCE-project/PARCE-1, and a Docker container can be
downloaded from: https://hub.docker.com/r/rochoa85/parce-1
1. Introduction
The rational design of proteins and peptides is a field that has been
explored through experimental and computational approaches [1]. When
detailed information of a particular system is available, conventional
knowledge-based methods provide tools for the design of more active
analogs [2]. However, detailed information is not always available, and thus,
de novo design strategies are required.
Due to the significant amount of information related to the properties of
natural amino acids, one strategy is to design proteins and peptides by
modifying directly the amino acid sequence, without taking into account
the structure. This strategy is commonly used in the design of
antimicrobial peptides, where the mechanism of action has been elucidated
for some families [3]. Physico-chemical properties such as hydrophobicity,
charge, and molecular weight, have been used to create libraries of analogs
with potentially similar activities [4]. However, these strategies lack
information about the interacting partners, and on how the conformational
landscape of the residues can affect their activity [5]. This motivates the
use of structure-based design [6, 7].
The most used structure-based strategies are molecular docking and the
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use of structural libraries. Approaches based on experimental structural
databases take advantage on the huge quantity of protein structural
information to predict and optimize the most probable binding
conformations [8, 9, 10]. Molecular docking identifies the most probable
poses of potential active molecules ranked by scoring functions that roughly
approximate binding free energies or discriminate between active molecules
and decoys [11, 12]. In spite of these scoring-function improvements,
protein and peptide design is still a computational challenge due to the
large sequence space that has to be explored (e.g., for a peptide of 10 amino
acids in length, 2010 sequences are possible). In addition, the intrinsic
flexibility of non-structured protein regions, such as peptides or the
complementary determining regions of antibodies, and the constraints
associated to the protein interface region affect the reliability of the
prediction [13]. To solve some of these problems, it has been proposed to
sample the bound conformations using Molecular Dynamics (MD) [14].
The prediction of the binding affinities is another challenge associated
to the design. Different alternatives exist based on the biological system
and the available computational infrastructure. One option is the use of
representative structures from MD trajectories to calculate energy terms
based on molecular mechanics assumptions, entropy terms and free energies
of solvation using continuum-solvent models [15, 16, 17]. However, these
approaches are computationally expensive. An alternative is averaging the
scoring over conformational ensembles to estimate the affinity [18, 19, 20].
We here describe a new tool for performing peptide and protein design
using MD. We called this tool Protocol for Amino acid Refinement through
Computational Evolution (PARCE). The algorithm implemented in
PARCE is inspired by previous projects related to the exploration of the
sequence space of peptides bound to proteins or small molecules
[21, 14, 22]. The algorithm includes a single-point mutation protocol, which
has been optimized for predicting the most common rotamers of peptide
amino acids [5], an all-atom MD simulation of the mutated complex and
the estimate of the average score of the conformations from the trajectory
to assess the impact of the mutation in the binding [14, 23]. This approach
has been successfully used to design peptides and protein fragments, whose
binding affinity was afterward confirmed experimentally [24, 18, 25].
PARCE implements multiple scoring functions that are evaluated using a
consensus metric for accepting or rejecting the mutations [25]. The process
is iterated with the aim to evolve the original sequence and explore
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efficiently novel sequences with potential better affinities toward their
targets [7]. Figure 1 shows a graphical summary of PARCE.
Figure 1: Summary of PARCE, which is composed of different phases. First, a starting
protein-peptide or protein-protein complex is used. Then, the MC cycle starts by
generating a single-point mutation of a random amino acid in the peptide structure. Then,
the conformational sampling of the mutated system is done with MD simulations. Scoring
of the trajectory snapshots and the calculation of averages using multiple scoring functions
is performed. Finally, a consensus criterion accepts or rejects the mutation and an update
(or not) of the sequence is performed. The process is iterated.
The computational protocol presented in this work is open source. The
manuscript is organized as follows. First, we explain the code architecture,
the simulation parameters and the system used to test the PARCE
functionalities. Then, we include details about the code requirements and
the performance of the protocol using a protein-peptide system as a
reference. Finally we discuss PARCE features in comparison with those of
similar software.
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2. Methods
2.1. Code architecture
The code is written in Python 3, with calls to Unix command lines for
manipulation of files and external programs. Therefore, the current
protocol depends on the availability of a bash environment to run. To
guarantee reproducibility, a docker container is provided with all the
requirements, including the installation of the third-party open source
software, and the validation of the PARCE functionalities. However, a user
can configure her/his own machine following a simple setup validated with
the Travis CI framework (https://travis-ci.com). The documentation
illustrates the definition of the parameters, the input options and files (see
supplementary Table A1). Figure 2 shows a workflow of the protocol based
on the tasks, scripts and software implemented at each step. In the
following, we present a description of each stage of PARCE.
2.1.1. Input requirements and initial MD simulation
Before applying the design protocol it is necessary to perform an MD
simulation of the starting complex to equilibrate the system, and also to
obtain MD files required to start the protocol. When the starting system is
obtained from a docked structural complex or a crystal structure, a longer
previous sampling of the complex is suggested. The equilibration of the
complex can be detected using the RMSD or observables such as the number
of hydrogen bonds between the peptide and protein. We note that for most
systems 200 ns is suitable for this purpose. If the protocol starts from a
crystallized protein-peptide complex, the initial sampling time could be lower
[24].
The workflow requires as input:
• A PDB and GRO (Gromacs format) file of the protein-peptide complex
solvated and equilibrated with MD using the Gromacs package [26].
• Topology files and MD parameters definitions.
The protocol starts with an initial NPT simulation of the system using
the Gromacs configuration files (i.e. mdp files). Advanced users have the
possibility of modifying the Gromacs configuration files for adapting these to
simulate the specific systems.
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Figure 2: Workflow of PARCE. The protocol is managed by the script run protocol.py,
which accepts as input a configuration file with all the parameters required to run the
design, and a folder with the structural input obtained from a previous MD trajectory.
After configuring all the files and folders, and runing MD simulations of the initial complex,
the first step is to perform a single-point mutation with the mutation.py script, which
selects a random position on the peptide and modifies its side chain by a random amino
acid. From there, the second step is to call the general.py script, responsible to sample
the new system. The third step is to score the trajectory using a set of scoring functions
available in the scoring.py file. The fourth step is to verify if the score difference between
the current state and the previous one satisfies a consensus threshold. If that happens
then the system is updated. The process is repeated during a number of attempts defined
by the user.
2.1.2. Main script
The code has the main script run protocol.py, which calls three main
modules: general functions, scoring functions and mutation functions. The
general module creates an object responsible to run the simulations,
perform the random mutations and score the trajectories to accept or reject
the mutations. In a folder called design output, all the results are stored
step-by-step, including the different molecular entities (in complex or
isolated), as well as the MD trajectories, the log files and the scores
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calculated for each frame. In the end, a report file summarizes the
mutations attempted, if accepted or rejected, the average scores of each
function and the updated peptide sequence. An example is provided in
supplementary Table A2. The number of MC steps and the MD simulation
time can be modified for making the protocol computationally efficient.
2.1.3. Mutation protocol
The script mutation.py randomly performs a single-point mutation over
the peptide. Currently, the code randomly selects a residue on the peptide
chain and performs a random mutation using a uniform distribution for the
aminoacids. However, this procedure can be customized, for example, by
avoiding certain problematic amino acids, such cysteines, or including a non-
uniform probability distribution for the location or aminoacid-type mutation.
The prediction of the new amino acid rotamer is made with Scwrl4
[27, 28], which selects the side chain conformations based on a library of
backbone-dependent rotamers previously extracted from crystallized protein
structures. The program was chosen based on a previous assessment of
different mutation protocols to predict amino acid rotamers most similar to
those frequently explored by MD trajectories of protein-peptide systems [5].
The mutation is first generated over the complex without solvent. Then a
first minimization is ran with the predicted side chain alone. Then the
mutated complex is combined with the equilibrated solvent box from the
input structure file, and a second minimization is ran with the new amino
acid and the water molecules surrounding it within 2A˚. This is done to
avoid clashes between the new side chain and water molecules, which could
crash the simulation. If the minimization crashes, the protocol attempts a
new mutation, which is be repeated based on a number of times defined at
the beginning by the user. If the protocol continues presenting
minimization problems, the new mutation is generated using as reference
the last accepted sequence. If the problems persists, the protocol stops. In
addition, it is possible to minimize the input structure before mutating to
avoid protein-solvent overlaps. Finally, the complete system is minimized
and subjected to NVT equilibration of 100 picosencods (ps). Details of the
MD simulations are described next.
2.1.4. Conformational sampling
The script general.py runs the MD simulations using Gromacs [26]. The
current PARCE code was tested using version 5.1.4, but any higher version
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can be also selected by providing the path in the configuration file (see
supplementary Table A1). The MD simulation time is defined by the user,
which by default is 10 nanoseconds (ns) per run. This production run is
performed in the NPT ensemble after minimizing and equilibrating the
system. The Amber99SB-ILDN protein force field [29] is selected, with a
TIP3P water model [30], a Parrinelo-Rahman barostat [31] and a modified
Berendsen thermostat [32]. The Particle Mesh Ewald method (PME) is
used to calculate electrostatic interactions with a threshold of 1.0 nm [33].
The leap-frog integrator [34] is used to integrate the equations of motion
with a timestep of 2 femtoseconds (fs). A standard temperature of 310K is
selected by default to run the simulations. We note that these variables can
be modified directly in the Gromacs configuration files depending on the
system and the preferred conditions. After each run, the trajectory and the
simulation-log files are stored for further analysis.
2.1.5. Scoring functions
The script scoring.py implements a scoring approach over the
conformations from the complex trajectory. Its objective is to rank the
mutated complex by comparing the predicted activity to that of the
previous complex. A set of scoring functions used for protein-protein and
protein-peptide affinity predictions are implemented to score each snapshot
and obtain an average score for each function. The average can be
calculated over all the trajectory frames, or just the last half of the
simulation. The code includes six scoring functions: BACH [35, 36, 37],
Pisa [38], FireDock [39], Irad [40], Zrank [41], BMF-Bluues [42, 43] and
DFIRE-GOAP [44, 45] combinations. These software packages are open
source and are distributed with the PARCE code.
2.1.6. Consensus strategy
The mutation is accepted or rejected based on a consensus criterion
using multiple scoring functions. The sign of the score difference between
the new sequence and the previous one indicates if the mutation is
favorable or not for each scoring function. In this scenario, a negative sign
of the difference means a potentially better affinity when the mutation is
performed. The consensus criterion states that if the number of scoring
functions that consider the mutation favorable is higher than a defined
threshold, then mutation is accepted [25]. By default the consensus
threshold is three, but this value can be changed by the user. The
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implemented scores can be customized by the user, and additional scoring
functions can be added if necessary. After that, the protocol iterates over
the three main phases (mutating, sampling and scoring) and a number of
attempted modifications is achieved (Figure 2).
2.1.7. Output files
After running PARCE with a system of reference, a set of folders
containing structures of each iteration, the MD trajectories, the calculated
scores and the sampling log files are generated locally. The explanation of
the folders is provided in supplementary Table A3. The files and final
report can be used for further analysis of the best sequence candidates.
3. Results
3.1. Code insights
PARCE can be installed under any Linux operating system. However, the
code was optimized for Debian and Ubuntu OS distributions. PARCE can
be managed also through a docker container provided in the repository. We
should note that the computational resources required for running PARCE
are determined by the complexity of the system, since the design is based on
running MD. A configuration file describes the path and characteristics of the
input files, as well as the necessary parameters to run the design protocol. An
explanation of the parameters and output files is provided in Supplementary
tables. The code contains instructions to configure the system and launch
the protocol. We note that all the dependencies required to run PARCE are
open source software, but some of them, such as Scwrl4, require academic
licences. In such cases, it is recommended to install these packages following
the developer’s documentation to integrate their paths to the code. A list
of all the required software, including the scoring functions, is provided in
Table 1. All the steps associated to the mutation protocol, the sampling of
the peptide-protein system and the application of scoring functions have been
optimized in previous works of specific systems, supporting the choice of the
default parameters. [5, 18, 14]. PARCE has an MIT licence that allows for
the distribution of the code and its improvement through new functionalities.
3.2. Design of peptides bound to a protease
As a tutorial, we use a protease in complex with a modelled peptide.
The protease is obtained from the crystallized structure (PDB code 1ppg).
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Table 1: List of third-party tools and scoring functions required to run the PARCE.
Name Version/Year
Gromacs 5.1.4
Scwrl 4.0
GromacsWrapper (Python3) 0.8
BioPython (Python3) 1.76
PDB2PQR 2.1.1
Bluues 2.0
BMF 3.0
Pisa 2011
Zrank 2007
BACH 6.0
DFIRE-GOAP 2011
FireDock 2007
Irad 2011
This is a neutrophil elastase, which is a serine protease part of the
chymotrypsin family [46]. The enzyme is bound to a peptidomimetic
inhibitor, so we modified its sequence to model a reported peptide-substrate
available in the MEROPS database [47]. Specifically, the protease binding
pockets were annotated according to its catalytic site. Then, the modified
amino acids were replaced by natural amino acids found in the substrate
sequence using Scwrl4. The peptide was completed to reach a final size of
eight amino acids (AAPAAAPP), which is characteristic of these proteas e
peptide binders [48]. These missing amino acids were predicted with the
Modeller software [49]. The created complex was subjected to 100 ns of MD
simulations using the same MD configuration as explained previously. We
ran the PARCE protocol to perform 30 random mutation attempts, using
six scoring functions with a consensus threshold of three. The evolution of
the scores was monitored to check if the scores -on average- decreased as a
function of the MC iteration step.
The protocol was ran using 5 ns of conformational sampling per
mutation for 30 attempts. For this specific run, a total of 6 mutations were
accepted based on the consensus criterion explained in Methods (i.e., if
three or more scores consider the mutation as favorable then it is accepted).
During the PARCE run it is important to monitor if the scoring functions
are -on average- lowering their values. An example is shown in Figure 3 for
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the scoring function BMF-Bluues. The sequence of the peptide should
evolve towards a sequence with potentially better affinity.
Figure 3: Example of a PARCE run showing one (BMF-Bluues) of the 6 scoring functions
with the protease-peptide system (see the Methods). The dots represent the mutations
that were accepted, with the structure of the protein in orange, the peptide in purple, and
the accepted mutations in green.
Despite the ideal behavior of BMF-Bluues, some of the scoring functions
have slightly different behaviours. An example of three other scoring
functions behaviour is shown in Figure 4. For three of the four plotted
functions, the scores get lower in the last steps. In the case of the
DFIRE-GOAP combination (Figure 4D), the score fluctuates up and down
without a defined trend. The consensus methodology ensures that on
average most -but not all- of the scoring functions decrease. Therefore, if
there is a poor-performing scoring function the method does not force it to
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minimize (e.g., DFIRE-GOAP in Figure 4). This is an advantage because
some scoring functions might perform well for some particular systems but
fail for others, and knowing beforehand which scoring functions are the best
for a particular system is challenging. We note that the evolution is
stochastic (due to the random mutations) therefore for different runs there
could be different behaviors. However, if most of the scoring functions have
an erratic performance, then the scoring function configuration should be
re-evaluated. The user has the possibility to modify the selection of the
scoring functions and the threshold to define if a mutation is accepted or
not. Moreover, if the system has available binding data, it might be useful
to benchmark the MD/scoring methodology with it. We applied the latest
in the case of the Major Histocompatibility Complex class II (MHC-II),
where we benchmarked a set of scoring functions and MD configurations to
rank bound peptides in agreement with available experimental data [24].
We note that we have tested protocol extensively over other protein-
peptide systems [7, 18].
3.3. Technical considerations
Because the methodology is computationally expensive, the
implementation can take weeks of calculations for running 50 or 100
mutation-attempts, depending on the system and the available
computational resources. The PARCE computational cost is dominated by
the MD simulation time (i.e., number of ns) multiplied by the number of
mutation attempts. Other relevant factors are the system size, and the
number of frames used to score the trajectories. We recommend to
configure the protocol to have a sufficiently good MD sampling and a
number of mutation-attempts sufficient to explore efficiently the peptide
sequence space.
4. Discussion
The PARCE code is an open source software to design peptides or proteins
capable of binding with higher affinity to a protein target. The method
combines computational biophysics tools with bioinformatics, in order to
achieve an equilibrium between accuracy and computational efficiency. One
advantage is the possibility to obtain in an stochastic way peptide candidates,
which can be different independent runs. This increases the pool of sequences
available for further filtering and validation. This is an advantage against
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Figure 4: Evolution of four of the six scoring functions used in PARCE for the example
run with the protease-peptide system. The large and red dots correspond to the accepted
and rejected mutations, respectively. The results are shown for (A) BMF-Bluues (same
data as in Figure 3), (B) Pisa, (C) Firedock and (D) DFIRE-GOAP.
more deterministic or brute force alternatives. Moreover, since the code is
open source, it is possible to improve it according to the research-project
needs.
Most of the available protocols of peptide design have been built also
with open source software, and some are available to users through web
servers. This is the case of Peptiderive, which identifies the linear
polypeptide segment that contributes most to the binding energy given a
protein-protein interaction structure [50]. Another server, PepComposer,
requires only the target protein structure in order to retrieve a set of
peptide-backbone scaffolds derived from monomeric proteins. Then, the
peptides are optimized using a set of iterative mutations through controlled
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backbone movements [51]. Finally, other initiatives about the sampling and
scoring peptides as binders are also available as web servers or code
protocols that can be customized [52, 53, 54].
Despite the efforts, the balance between the computational efficiency
and biological accuracy is still a major challenge, motivating the
development and validation of novel pipelines as the one proposed here.
PARCE can accelerate the discovery of novel peptides as potential
therapeutics, biomarkers or vaccine sub-units. The code is flexible. It
allows adding protocols to modify different types of molecular targets, such
as small molecules, contributing to the engineering of peptides and proteins
for a broad spectrum of applications.
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Appendix A. Supplementary tables
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Table A1: Parameters provided by the user in the configuration file.
Parameter Explanation
folder Name of the folder that has all the input and output files of
the protocol
mode The design mode, which has three possible options: start
(start the protocol from zero), restart (start from a particular
iteration of a previous run) and *nothing* (just run without
modifying existing files)
peptide reference The sequence of the peptide, or protein fragment that will be
modified
pdbID Name of the structure that is used as input, which contains
the protein, the peptide/protein and the solvent molecules
chain Chain id of the peptide/protein in the structural complex
sim time Time in nanoseconds that will be used to sample the complex
after each mutation
num mutations Number of mutations that will be attempted
try mutations Number of mutations tried after having minimization or
equilibration problems
residues mod These are the specific positions of the residues that want to
be modified. This depends on the peptide/protein length and
the numbering in the PDB file
md route Path to the folder containing the input files, which are the
files used during the previous MD sampling of the system
md original Name of the system file located in the folder containing the
previous MD sampling
score list List of the scoring functions that will be used to calculate the
consensus. Currently the package only has available the code
for six of them: BACH, Pisa, ZRANK, IRAD, BMF-BLUUES
and FireDock
half flag Flag that controls which part of the trajectory is used to
obtain the average score. If 0, the full trajectory is used,
if 1, only the last half
threshold Threshold used for the consensus. If the number of scoring
functions in agreement are equal or greater than the threshold,
then the mutation is accepted.
scwrl path Provide the path to Scwrl4 in case it is not installed in a
PATH folder.
gmxrc path Provide the path to GMXRC for Gromacs.
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Table A2: Example of PARCE report using as input a peptide binder with sequence
AAPFAAPP. The report includes the iteration number, the mutation, the acceptance, the
average scores and the attempted peptide sequence.
Iteration Mutation Status BACH Pisa Zrank Irad BMF-BLUUES Firedock Sequence
1 AB4F Accepted -3.514 -0.209 -59.637 -101.285 -30.542 -44.041 AAPFAAPP
2 AB2G Rejected -4.705 -0.198 -56.245 -101.161 -34.482 -37.784 AGPFAAPP
3 PB3Q Accepted -4.128 -0.273 -63.155 -108.444 -34.122 -46.402 AAQFAAPP
4 PB8R Rejected -3.568 -0.237 -56.869 -100.154 -32.223 -37.734 AAQFAAPR
5 AB1Q Accepted -3.463 -0.245 -65.987 -116.340 -35.730 -47.378 QAQFAAPP
Table A3: Folders with the output files generated by PARCE.
Folder Explanation
binder Store the peptide/protein structure after each mutation
attempt
target Store the target structure after each mutation attempt
complexP Store the target-peptide/protein structure after each
mutation attempt
solvent Store the solvent box after each mutation attempt
system Store the complete target-peptide/protein-solvent
complex after each mutation attempt
trajectory Store the MD trajectory of the previous mutations
score trajectory Store the average scores for each snapshot from the
trajectories. The file is split into four columns. The
first column is the score of the complex. The second
and third are the scores for the receptor and peptide
alone. The fourth column is the total score after doing
the difference between the complex and each component
log npt Store the log file from each npt run to verify possible
errors
log nvt Store the log file from each nvt run to verify possible
errors
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